Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants

By Birnbaum Howard G.  

PharmacoEconomics, Vol. 27, Iss. 6, 2009-06 ,pp. : 507-517

Adis International

Access to resources Recommend Favorite

Influenza immunisation for US employees worth its cost

By  

Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

The Economic Cost of Multiple Sclerosis in Sweden in 1994

By Henriksson F.   Jönsson B.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 597-606

Adis International

Access to resources Recommend Favorite

The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment

By Phillips C.J.  

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 561-574

Adis International

Access to resources Recommend Favorite

Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability

By Panitch Hillel   Applebee Angela  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1511-1521

Informa Healthcare

Access to resources Recommend Favorite